Capricor EVP Krasney Completes $752,935 Share Sale, Exercises 25,000 Options
Karen Krasney, Executive Vice President and General Counsel of Capricor Therapeutics (NASDAQ: CAPR), sold 25,000 shares on March 31, 2026 for $752,935 and simultaneously exercised options to acquire 25,000 shares. The disposal was carried out under a pre-established 10b5-1 trading plan. Capricor recently reported a Q4 fiscal 2025 EPS miss and conti…